Recently, Qu et al. reported that MSCs with GOF mutation of SHP2 recruit monocytes through CCL3 signaling and monocyte-mediated interlukin-1b pathway to promote HSC malignant proliferation and eventually lead to MPN [14]. The gene discussed is PTPN11; the disease is myeloproliferative disorder.